Safe and prolonged survival with long-term exposure to pomalidomide in relapsed/refractory myeloma. - Fouquet, G.; Pegourie, B.; Macro, M.; Petillon, M. O.; Karlin, L.; Caillot, D.; Roussel, M.; Arnulf, B.; Mathiot, C.; Marit, G.; Kolb, B.; Stoppa, A. M.; et al. (Annals of Oncology, 2016)